Circulating tumor cell counts are prognostic of overall survival in SWOG S0421: a phase III trial of docetaxel with or without atrasentan for metastatic castration-resistant prostate cancer.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Nicholas J. Vogelzang Michael A. Carducci Celestia Higano David I Quinn Catherine M Tangen |
| Publication date | March 10, 2014 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |